PHILADELPHIA, Feb. 23, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc.(NYSE Amex:HEB) (the “Company”), announces that the Company has recently secured all material rights, primarily for future and potential internet commercial applications, in www.Ampligen.com, and, www.Hemispherx.com. The Company has as its present website, www.Hemispherx.net. From this point forward, any web inquiries to either www.Ampligen.com or www.Hemispherx.com will automatically revert to the existing website, which will make it easier for interested parties to find information about the Company, its development programs, and its products.
